Product name: Stanozolol (Winstrol)
CAS NO.: 10418-03-8
EINECS: 233-894-8
Assay: 98%
Molecular Formula:C21H32N2O
Molecular Weight:328.49
Packing:1kg/tin
Form:Oral Steroids
Appearance: White or almost white crystalline powder, odorless. Almost insoluble in water, soluble in alcohol, chloroform, slightly soluble in acetone
Usage: For chronic wasting disease, illness and surgery frail thin, frail, osteoporosis, stunted children, aplastic anemia, etc.
Categories: Pharmaceutical; Active Pharmaceutical Ingredients; Biochemistry; Steroids (Others)
Description:It is a synthetic anabolic steroid derived from dihydrotestosterone. It was developed by Winthrop Laboratories (Sterling Drug) in 1962, and has been approved by the FDA for human use.
Stanozolol has been used in both animal and human patients for a number of conditions. In humans, it has been demonstrated to be successful in treating anaemia and hereditary angioedema. Veterinarians may prescribe the drug to impr
CAS NO.: 10418-03-8
EINECS: 233-894-8
Assay: 98%
Molecular Formula:C21H32N2O
Molecular Weight:328.49
Packing:1kg/tin
Form:Oral Steroids
Appearance: White or almost white crystalline powder, odorless. Almost insoluble in water, soluble in alcohol, chloroform, slightly soluble in acetone
Usage: For chronic wasting disease, illness and surgery frail thin, frail, osteoporosis, stunted children, aplastic anemia, etc.
Categories: Pharmaceutical; Active Pharmaceutical Ingredients; Biochemistry; Steroids (Others)
Description:It is a synthetic anabolic steroid derived from dihydrotestosterone. It was developed by Winthrop Laboratories (Sterling Drug) in 1962, and has been approved by the FDA for human use.
Stanozolol has been used in both animal and human patients for a number of conditions. In humans, it has been demonstrated to be successful in treating anaemia and hereditary angioedema. Veterinarians may prescribe the drug to impr
Main Products
pharmaceutical raw materials, preparation, pharmaceutical intermediate